"Drug of Monetization:" How Profits Can Accelerate GOOGL Innovation
We're back on Morning Trade Live. Let's focus on Alphabet. Shares are up nearly 30% this year, and nearly half of that gain has come since September the 2nd.That's when a district court ruled that Google would not have to divest its Chrome browser as part of an antitrust case. Alphabet hit its all-time high on September the 19th, and shares are trading just 5% below that mark. Wedbush has a $245 price target on Alphabet.And joining us now is Scott Devett, managing director of equity research at Wedbush Secu ...